ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,566Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 403

$816K Total Retail Price of All Prescriptions

Rank: 12 out of 403

432 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,220 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 313 270 1 3
SIMVASTATIN 309 240 2 2
FUROSEMIDE 309 262 2 7
TRAMADOL HCL 198 173 4 28
DIOVAN 197 182 5 24
AMLODIPINE BESYLATE 191 178 6 4
METOPROLOL TARTRATE 180 166 7 10
ATORVASTATIN CALCIUM 174 157 8 5
AZITHROMYCIN 159 140 9 49
ALLOPURINOL 138 98 10 31
METFORMIN HCL 137 90 11 8
MELOXICAM 134 116 12 58
GLIMEPIRIDE 125 98 13 61
ZOLPIDEM TARTRATE 123 123 14 16
TAMSULOSIN HCL 122 118 15 27
HYDROCHLOROTHIAZIDE 115 115 16 6
OMEPRAZOLE 112 95 17 9
DONEPEZIL HCL 106 106 18 23
GABAPENTIN 105 70 19 17
BENICAR 105 100 19 112
LOSARTAN POTASSIUM 101 85 21 21
CITALOPRAM HBR 100 98 22 22
ATENOLOL 93 87 23 13
VENLAFAXINE HCL ER 86 64 24 95
CRESTOR 86 50 24 19
METOPROLOL SUCCINATE 84 84 26 11
CEPHALEXIN 82 66 27 133
PANTOPRAZOLE SODIUM 81 70 28 30
PAROXETINE HCL 75 74 29 68
LISINOPRIL 74 60 30 1
NEXIUM 74 39 30 18
BYSTOLIC 73 57 32 94
WARFARIN SODIUM 70 66 33 12
SYNTHROID 64 64 34 51
PROAIR HFA 63 54 35 40
DIOVAN HCT 61 55 36 69
TRILIPIX 58 27 37 155
SERTRALINE HCL 58 49 37 20
CLOPIDOGREL 53 53 39 55
DOXEPIN HCL 53 47 39 253
CYMBALTA 51 18 41 43
SINGULAIR 50 36 42 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.